DDAVP in type IIa von Willebrand's disease

1-D-Amino(8-D-arginine)-vasopressin (DDAVP) infusion in three patients with type IIa von Willebrand's disease (vWD) resulted in a normalization of the factor VIII coagulant, factor VIII-related antigen, and von Willebrand factor (vWF) (ristocetin cofactor) activities and the bleeding time. The normalization of these hemostatic parameters persisted for four hours. Over the same time period there was a marked increase in the quantity of the vWF multimers when blood was collected in the presence of protease inhibitors. The vWF multimers present were even larger than the normal. When blood was collected in the absence of protease inhibitors, a smaller increase in the plasma vWF multimers was observed and fewer of the intermediate and larger vWF multimers were seen; multimers larger than those present in normal plasma were not visualized. The platelet vWF multimers and activities did not change with or without inhibitors. These studies suggest that there is a subgroup of patients with type IIa vWD who respond to DDAVP with complete normalization of their hemostatic abnormalities and whose vWF is sensitive to proteolysis.     

Infection in diabetic osteoarthropathy: use of indium-labeled leukocytes for diagnosis

Indium-111 labeled leukocyte imaging was compared with three-phase skeletal scintigraphy as a means of determining whether osteomyelitis was complicating diabetic osteoarthropathy. Three-phase scintigraphy demonstrated increased activity in both infected and noninfected osteopathic bone, with a sensitivity of 75% and a specificity of 56% for osteomyelitis. Leukocyte imaging had the same sensitivity but was most helpful for excluding infection (specificity, 89%) when three-phase imaging could not. Abnormal leukocyte localization was seen at the primary site of infection in all cases within 4 hours after injection. Disadvantages of leukocyte imaging included long preparation time, low count rates resulting in poor spatial resolution, and absence of bone landmarks, which made it difficult to differentiate soft tissue from bone infection.     

Percutaneous cholecystostomy: anatomic considerations

In 100 consecutive patients undergoing abdominal computed tomography, the anatomic relationships among the gallbladder fundus, liver, and right hemicolon were evaluated to assess the feasibility of direct transperitoneal versus percutaneous transhepatic cholecystostomy. In only 17% of patients was there no interposition of colon or liver between the skin and the gallbladder fundus. In 13% of patients the right hemicolon lay between the gallbladder fundus and skin. In the remaining 70% of patients, the gallbladder fundus was positioned posterior to the liver margin. Thus, in 83% of patients studied, percutaneous cholecystostomy would necessitate a transhepatic approach.     

Postoperative abscesses with enteric communication: percutaneous treatment

Patients with abscesses that have enteric communication in the absence of underlying inflammatory bowel disease require modification of the usual percutaneous treatment techniques. An ongoing source of output (gastrointestinal secretions) is a complicating factor in treatment. The results of percutaneous treatment of 17 abscesses with enteric communication in 16 patients without a history of inflammatory bowel disease were reviewed. The long-term cure rate was 71%. Pancreatic involvement in abscess-bowel communication diminished the cure rate to 50% (two of four) and lengthened the duration of drainage required. The results suggest that percutaneous treatment of abscesses with enteric communication is a viable alternative to surgical intervention. Minimal morbidity and no mortality were directly attributable to percutaneous therapy in this series. When the pancreas is involved in the establishment or persistence of the abscess-bowel communication, or when the underlying bowel is diseased, the rate of success decreases.